Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Breast Neoplasms, Male × Busulfan × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Myeloproliferative Disorders 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hematologic Neoplasms 5 Leukemia, Biphenotypic, Acute 4 Neuroblastoma 3 Lymphoproliferative Disorders 3 Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Leukemia 3 Primary Myelofibrosis 2 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Hematologic Diseases 2 Graft vs Host Disease 2

Interventions

exemestane 2 Tamoxifen 2 Leuprolide 2 Letrozole 2 Immunotherapy 2 Goserelin 2 Anastrozole 2 ribociclib 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 abemaciclib 1 Neoadjuvant Therapy 1 Immunoenzyme Techniques 1 Everolimus 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡